Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non-small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy.

ABSTRACT:

SUBMITTER: Chu T 

PROVIDER: S-EPMC10230154 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature